Growth Metrics

Eli Lilly (LLY) EPS (Basic) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.76%
Dec 31, 2025 18.97%
Sep 30, 2025 -1.27%
Jun 30, 2025 105.21%
Mar 31, 2025 -37.35%
Dec 31, 2024 353.70%
Sep 30, 2024 -67.17%
Jun 30, 2024 32.13%
Mar 31, 2024 2.47%
Dec 31, 2023 4,150.00%
Sep 30, 2023 -103.06%
Jun 30, 2023 31.54%
Mar 31, 2023 -30.70%
Dec 31, 2022 33.54%
Sep 30, 2022 51.89%
Jun 30, 2022 -49.76%
Mar 31, 2022 11.05%
Dec 31, 2021 55.74%
Sep 30, 2021 -20.26%
Jun 30, 2021 2.68%
Mar 31, 2021 -36.05%
Dec 31, 2020 75.19%
Sep 30, 2020 -14.74%
Jun 30, 2020 -2.50%
Mar 31, 2020 -2.44%
Dec 31, 2019 19.71%
Sep 30, 2019 -4.86%
Jun 30, 2019 152.63%
Mar 31, 2019 -48.65%
Dec 31, 2018 3.74%
Sep 30, 2018 586.36%
Jun 30, 2018 -118.97%
Mar 31, 2018 173.42%
Dec 31, 2017 -398.11%
Sep 30, 2017 -44.79%
Jun 30, 2017 1,060.00%
Mar 31, 2017 -113.70%
Dec 31, 2016 -1.35%
Sep 30, 2016 4.23%
Jun 30, 2016 69.05%
Mar 31, 2016 -6.67%
Dec 31, 2015 -40.00%
Sep 30, 2015 31.58%
Jun 30, 2015 14.00%
Mar 31, 2015 25.00%
Dec 31, 2014 -14.89%
Sep 30, 2014 -30.88%
Jun 30, 2014 0.00%
Mar 31, 2014 0.00%
Dec 31, 2013 -38.74%
Sep 30, 2013 -0.89%
Jun 30, 2013 -21.13%
Mar 31, 2013 89.33%
Dec 31, 2012 -36.44%
Sep 30, 2012 42.17%
Jun 30, 2012 -8.79%
Mar 31, 2012 18.18%
Dec 31, 2011 -30.63%
Sep 30, 2011 3.74%
Jun 30, 2011 12.63%
Mar 31, 2011 -9.52%
Dec 31, 2010 -11.02%
Sep 30, 2010 -3.28%
Jun 30, 2010 7.96%
Mar 31, 2010 36.14%
Dec 31, 2009 -3.49%
Sep 30, 2009 -18.87%